March 5, 2018 / 9:50 PM / 7 months ago

BRIEF-Foundation Medicine Enters Into Amended And Restated Ex-US Commercialization Agreement With F. Hoffmann-La Roche Ltd

March 5 (Reuters) - Foundation Medicine Inc:

* FOUNDATION MEDICINE SAYS ON FEB 28, CO ENTERED INTO AMENDED AND RESTATED EX-US COMMERCIALIZATION AGREEMENT WITH F. HOFFMANN-LA ROCHE LTD - SEC FILING

* FOUNDATION MEDICINE INC - AGREEMENT AMENDS AND RESTATES THAT CERTAIN EX-US COMMERCIALIZATION AGREEMENT, EFFECTIVE AS OF APRIL 7, 2015

* FOUNDATION MEDICINE- PER AGREEMENT, ROCHE HAS EXCLUSIVE RIGHT IN TERRITORY TO COMMERCIALIZE CO'S CLINICAL DIAGNOSTIC TESTING COMMERCIAL PRODUCTS

* FOUNDATION MEDICINE INC - INITIAL TERM OF AGREEMENT EXPIRES ON APRIL 7, 2020 AND MAY BE EXTENDED BY ROCHE FOR ADDITIONAL TWO-YEAR PERIODS Source text (bit.ly/2FiMt07) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below